Navigation Links
Accuro Healthcare Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering
Date:1/24/2008

DALLAS, Jan. 24 /PRNewswire/ -- Accuro Healthcare Solutions, Inc. announced today it has filed a registration statement with the Securities and Exchange Commission relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering has not yet been determined.

Citi is acting as sole book-running manager for the offering, and Citi and Piper Jaffray are acting as joint lead managers for the offering. William Blair & Company and Jefferies & Company, Inc. are acting as co-managers for the offering.

The offering will be made only by means of a prospectus. When available, a copy of the prospectus may be obtained by submitting requests to Citigroup Global Markets Inc., Attention: Prospectus Department, Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, New York 11220; phone: 718-765-6732; fax: 718-765-6734.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This communication does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Accuro

Accuro is a leading provider of proprietary internet-based solutions to a broad range of healthcare providers, including hospitals and ancillary healthcare providers, which enable them to more effectively manage the complexities of the patient registration, billing, collection and reimbursement process.


'/>"/>
SOURCE Accuro Healthcare Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. MDS to Present at Thomas Weisel Partners Healthcare Conference
7. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
8. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
11. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...t 40% returned positive results in review of natio...hDay News) -- Colorectal cancer screening detects ...ned to be more effective, say Finnish Cancer Regis... aged 60 to 64, to determine how sensitive Finland...tifying unrecognized disease. Half the people were...
(Date:11/20/2008)...SSELS, BELGIUM A team of researchers at Duke Univ... de Louvain (UCL) has found that lactic acid is an...er experiments, they discovered a new way to destr... preventing them from delivering lactic acid. ,...xygen, or hypoxic, cells cause resistance to radia...
(Date:11/20/2008)...wswire/ -- The UNICEF supported clean-water,campa... water technology,manufacturer, The Watergeeks La...he campaign in 2009 -- the third year of this awar...provide clean water to children around the world. ...sed manufacturer will donate a,percentage of the ...
(Date:11/20/2008)...tes over $35,000 from Velocity hearing instrument ...ire-FirstCall/ -- Sonic Innovations, Inc. (Nasdaq:... the Armed Forces Foundation (AFF) during a check ...nt and COO Paul Wennerholm and AFF President and E... D.C. The donation is the result of a program con...
Breaking Medicine News(10 mins):Health News:Colorectal Cancer Screens Detect Unrecognized Disease 2Health News:Lactic acid found to fuel tumors 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 3Health News:Sonic Innovations Presents Donation to the Armed Forces Foundation 2Health News:Sonic Innovations Presents Donation to the Armed Forces Foundation 3
...h authorities and the state administration of Maha...eir inadequate handling of the Mumbai floods are n...already done to their image//. The health authori...new patients Monday as the outbreak of deadly post...
...en with early stage prostate cancer who make drast... perhaps even reverse the progression of their ill...rst randomized, controlled trials to demonstrate t...rogression of a cancer. Prostate cancer is the se...
...ted in the latest BMJ said that results of a rando...interviewing by midwives to help pregnant smokers ...vement in the smoking habits of the mothers//. A t...nt guidelines recommend that they should be offere...
...t short-acting Beta-agonist (SABA) prescriptions c...idity of steroid and non-steroid users//. Using cl...aid, with a diagnosis of asthma from fiscal year 1...m Chicago, IL, obtained the claims for SABA- and a...
Other Medicine News:Health News:Trained Counselors Counseling Pregnant Smokers To Quit May Not Work 2
(Date:11/20/2008)...-USNewswire/ -- The following is being released by... WHAT: World AIDS Day Audio Media Conference ,..., 11:00 a.m. EST , Call-in number: 1-800-949...eadytalk.com/r/1xe41i2yre8rs , , WHY: Wi...le newly put on treatment worldwide, advocates are...
(Date:11/20/2008)...S OF FIRST PHASE III TRIAL SHOW SIGNIFICANT, ...DAILY FUNCTION, IN, FI...BRUSSELS, Belgium, Nov. 20 /PRNewswire-FirstCall/,...nd UCB (Euronext Brussels: UCB),announced today p...t of two,Phase III pivotal clinical trials of sod...
(Date:11/20/2008)...Newswire-FirstCall/ -- Bionovo, Inc.,(Nasdaq: B...rom the Phase 1B,clinical trial of their lead dru..., BZL101, at the Society for Integrative Oncology,...gia. The Company,s oral presentation was selected...as a part of the Best of the,SIO Session on Novem...
(Date:11/20/2008)...-- Clinical data from a prospective,registry pres... shows DVT,treatment with the Trellis(R) Peripher...anta Clara, CA) successfully breaks up the blood c... This technique, called isolated pharmacomechanic... and safely than current catheter-directed thrombo...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Canadian Society of Exercise Physiology Annual Scientific Conference 1170 1Canadian Society of Exercise Physiology Annual Scientific Conference 1170 2Researchers successfully simulate photosynthesis and design a better leaf 1169 1Researchers successfully simulate photosynthesis and design a better leaf 1169 2Researchers successfully simulate photosynthesis and design a better leaf 1169 3Research highlights important indicators of early stage ovarian cancer 5988 1Abbott Donates Cool Globe to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center 5986 1Abbott Donates Cool Globe to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center 5986 2Abbott Donates Cool Globe to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center 5986 3
... - Pluristem Life Systems,Inc. (OTCBB:PLRS) (DAX:...commercialization of products for a variety of mal...announced today that,Pluristem,s PLacenta eXpanded...ve properties that the Company believes gives thes... (PD). PLX cells,are Pluristem,s placental-derived...
...vement in Signs and,Symptoms Of Moderate to Severe...chieving Disease Remission at One-Year,Mark , BA... show nearly,75 percent of patients with moderate ...mumab (CNTO 148) and methotrexate (MTX),experience...n,arthritis symptoms (ACR 20). This was according ...
Other Medicine Technology:Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 2Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 3Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 2Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 3Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 5
The Phoresis is a state-of-the-art digital imaging system which allows scanning and storage of electrophoresis results from any Sebia gel including immunofixation. This system provides benefits to an
LapEvac, designed for use during laparoscopic surgery, will help reduce many of the risks associated with poor vision and loss of distension due to smoke & efforts to clear smoke and aerosols from th
Inquire
Inquire
Medicine Products: